China Life
Deal focus: National team drives Hithium towards China IPO
Government and state-owned investors accounted for most, but not all, of Xiamen Hithium Energy Storage Technology’s USD 622m Series C, underlining where China’s strategic priorities lie
China EV battery solutions provider raises $229m
Sunwoda Electric Vehicle Battery (EVB), a subsidiary of lithium-ion battery maker Sunwoda Electronic, has raised a CNY 1.65bn (USD 229m) Series B round from domestic investors.
China Life, Qianhai Ark back ophthalmic device maker
China Life Private Equity and Shenzhen-based Qianhai Ark have led a CNY 300m (USD 44m) Series C round for Svision Imaging, a China-based ophthalmic device manufacturer.
ADIA, GIC lead $300m round for China's Taibang Biologic
Taibang Biologic Group, a specialist in blood plasma-based pharmaceuticals formerly known as China Biologic Products, has raised a USD 300m round led by Abu Dhabi Investment Authority (ADIA) and GIC.
China's METiS Pharmaceuticals raises $150m
METiS Pharmaceuticals, a Hangzhou-based drug formulation company has raised USD 150m through two funding rounds led by PICC Capital and China Life PE.
China medtech start-up SiBionics raises $79m
China-based medical technology start-up SiBionics has raised CNY 500m (USD 79m) in a third tranche of Series C funding co-led by CPE and China Life Investment.
China trucking player secures $200m Series E
For-U Smart Freight, a Chinese road freight logistics company, has raised a $200 million Series E round led by China Structural Reform Fund, China life Investment, and Greater Bay Area Homeland Investments.
JD Health targets largest Chinese PE-backed IPO in two years
JD Health, a Chinese online-to-offline healthcare business that raised around $1.9 billion from private investors after it spun out from JD.com, is looking to raise HK$26.9 billion ($3.48 billion) in its Hong Kong IPO.
Chinese mouse-based drug testing specialist raises $143m
Biocytogen, a Chinese contract research organization (CRO) that provides genetically-modified mice for drug testing, has raised RMB970 million ($143 million) in an extended tranche of Series D funding.
China's Biocytogen gets $78m Series D
Chinese contract research organization (CRO) Biocytogen has raised a RMB543 million ($78 million) Series D round led by China Life Insurance and SDIC Venture Capital, a VC arm of the State Development & Investment Corporation (SDIC).
China supply chain solutions provider gets $356m Series A
Shenzhen-based Zhunshida, or Jusida, a logistics spin-out from Foxconn International, has raised RMB2.4 billion ($355.8 million) in Series A funding led by China Life Insurance.
Deal focus: XtalPi takes big pharma into the cloud
China and US-based XtalPi has raised $61 million this year from investors impressed its use of quantum physics, computational chemistry, and artificial intelligence to bring greater certainty to drug development
Yunfeng, Alibaba agree $1.4b iKang take-private
The protracted pursuit of Chinese healthcare services provider iKang Healthcare Group appears to have ended, with Yunfeng Capital and Alibaba Group agreeing to buy the business at a valuation of around $1.4 billion.
Hillhouse, Sequoia join $2.5b round for JD.com's logistics unit
Chinese online retailer JD.com has raised approximately $2.5 billion for its logistics subsidiary from investors including Hillhouse Capital and Sequoia Capital China.
GLP, China Life establish $1.6b China logistics fund
GLP, a Singapore-headquartered warehouse operator formerly known as Global Logistic Properties that was acquired by a PE consortium last year, has established a RMB10 billion ($1.6 billion) China fund with China Life Insurance as the sole LP.
China’s United Imaging Healthcare raises $509m Series A
Shanghai United Imaging Healthcare, a China-based medical imaging device maker, has completed a RMB3.33 billion ($509 million) Series A round of funding co-led by state-backed SDIC Fund Management and China Life Healthcare Fund.
China Life, Baidu launch $1b tech PE fund
China Life Insurance Group and internet search giant Baidu have agreed to form a RMB7 billion ($1 billion) private equity fund to invest in technology companies.
China’s Gu Sheng Tang raises $150m in equity, debt funding
Gu Sheng Tang, a traditional Chinese medicine (TCM) clinic chain, has raised RMB1.01 billion ($150 million) in a Series D round comprising RMB510 million in equity and RMB500 million in debt.
China's Innovent Biologics gets $260m Series D round
A fund controlled by China’s State Development & Investment Corporation (SDIC) has led a $260 million Series D round of funding for Innovent Biologics, a domestic biopharmaceutical company working on treatments for cancer, autoimmune disorders and heart...
Chinese LPs: Untapped potential
Still at an early stage of its development, China’s LP community has minimal exposure to offshore private equity. Institutions with big checkbooks aren’t necessarily the fastest movers
Ride-hailing app Didi Chuxing to acquire Uber China
Didi Chuxing, the leading ride-hailing app operator in China, has announced that it will acquire Uber's local operation, ending a costly battle between the two unprofitable businesses. Both companies have received substantial private equity and strategic...
China's Didi Chuxing raises $7.3b in equity, debt financing
Didi Chuxing, China’s leading ride-hailing app operator, has raised $7.3 billion in new funding, comprising $4.5 billion in equity and $2.8 billion in debt. The round is said to value the company in excess of $25 billion.
China Life invests $600m in Didi Chuxing
China’s leading ride-hailing app operator Didi Chuxing has received about $600 million from China Life Insurance as part of its latest fundraising effort.
Hony, CIC among anchors for BOC Aviation IPO
Hony Capital and China Investment Corporation (CIC) are among the cornerstone investors for a HK$8.7 billion ($1.1 billion) Hong Kong IPO for Bank of China’s aircraft leasing business, BOC Aviation.